MK-0752

CAS No. 471905-41-6

MK-0752 ( MK0752;MK 0752 )

Catalog No. M14568 CAS No. 471905-41-6

A potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 86 In Stock
5MG 156 In Stock
10MG 234 In Stock
25MG 419 In Stock
50MG 615 In Stock
100MG 876 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MK-0752
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells.
  • Description
    A potent γ-secretase inhibitor that shows dose-dependent reduction of Aβ40 with an IC50 of 5 nM in human SH-SY5Y cells; Notch signaling inhibitor.Breast Cancer Phase 2 Clinical
  • Synonyms
    MK0752;MK 0752
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    γ-secretase
  • Recptor
  • Research Area
    Cancer
  • Indication
    Breast Cancer

Chemical Information

  • CAS Number
    471905-41-6
  • Formula Weight
    442.90
  • Molecular Formula
    C21H21ClF2O4S
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(O)CC[C@H]1CC[C@](C2=CC(F)=CC=C2F)(S(=O)(C3=CC=C(Cl)C=C3)=O)CC1
  • Chemical Name
    Cyclohexanepropanoic acid, 4-[(4-chlorophenyl)sulfonyl]-4-(2,5-difluorophenyl)-, cis-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cook JJ, et al. J Neurosci. 2010 May 12;30(19):6743-50.
2. Previs RA, et al. Clin Cancer Res. 2015 Mar 1;21(5):955-61.
3. Brana I, et al. Br J Cancer. 2014 Nov 11;111(10):1932-44.
molnova catalog
related products
  • BMS-433796

    A potent, orally active γ-secretase inhibitor with cell IC50 of 0.3 nM.

  • PF-06648671

    PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.

  • MRK-003

    A potent γ-secretase inhibitor with IC50 of 0.4 nM, inhibition of Aβ secretion from SH-SY5Y SPA4CT cells.